Hannover Medical School
Clinical trials sponsored by Hannover Medical School, explained in plain language.
-
New combo therapy for lung transplant patients shows promise in antibody clearance
Disease control CompletedThis study looked at 340 lung transplant patients who had donor-specific antibodies, which can cause organ rejection. They received a combination of immunoglobulin therapy, plasmapheresis, and rituximab. The goal was to see if the antibodies cleared and if the transplanted lungs …
Sponsor: Hannover Medical School • Aim: Disease control
Last updated Jun 27, 2026 12:00 UTC
-
Can blood filtering beat long COVID fatigue?
Symptom relief CompletedThis study tested a blood filtering procedure called immunoadsorption to see if it reduces fatigue in people with post-COVID syndrome. 63 patients received either the real procedure or a sham version over 14 days. The goal was to measure changes in fatigue and other symptoms like…
Phase: NA • Sponsor: Hannover Medical School • Aim: Symptom relief
Last updated Jun 26, 2026 17:05 UTC
-
Heart ablation may change stroke risk – new study investigates
Knowledge-focused CompletedThis study followed 167 people with atrial fibrillation or flutter who had a catheter ablation procedure. Researchers measured changes in stroke and bleeding risk scores before and 3, 6, and 12 months after ablation. They also compared different monitoring methods, including impl…
Sponsor: Hannover Medical School • Aim: Knowledge-focused
Last updated Jun 27, 2026 09:10 UTC
-
Beating heart machine tested in transplant study
Knowledge-focused CompletedThis study looked at how well a device called the Organ Care System (OCS) works for preserving donor hearts before transplantation. The OCS keeps the heart in a near-natural, beating state instead of on ice. Researchers followed 93 heart transplant recipients for 12 months to see…
Sponsor: Hannover Medical School • Aim: Knowledge-focused
Last updated Jun 27, 2026 07:53 UTC